Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Net Income (2016 - 2025)

Historic Net Income for Sunshine Biopharma (SBFMW) over the last 12 years, with Q3 2025 value amounting to -$883820.0.

  • Sunshine Biopharma's Net Income rose 2621.32% to -$883820.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 4180.64%. This contributed to the annual value of -$5.1 million for FY2024, which is 1393.84% down from last year.
  • Per Sunshine Biopharma's latest filing, its Net Income stood at -$883820.0 for Q3 2025, which was up 2621.32% from -$1.8 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Net Income peaked at $667116.0 during Q4 2021, and registered a low of -$23.5 million during Q4 2022.
  • Moreover, its 5-year median value for Net Income was -$1.3 million (2023), whereas its average is -$2.8 million.
  • Per our database at Business Quant, Sunshine Biopharma's Net Income plummeted by 362447.18% in 2022 and then skyrocketed by 9468.35% in 2023.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Net Income stood at $667116.0 in 2021, then tumbled by 3624.47% to -$23.5 million in 2022, then soared by 94.68% to -$1.3 million in 2023, then tumbled by 72.65% to -$2.2 million in 2024, then skyrocketed by 59.05% to -$883820.0 in 2025.
  • Its Net Income stands at -$883820.0 for Q3 2025, versus -$1.8 million for Q2 2025 and -$1.2 million for Q1 2025.